This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.

Accept
Creating a Future Immune to

Immunotherapy is the most promising cancer treatment of our time.
With your support, we can fund more breakthrough research
and more cures for cancers of all kinds.
Why Immunotherapy Support the Cause
87 Cents of every dollar spent goes to programs
All Cancers can potentially be treated with immunotherapy
$36.4 Million awarded in 2019
3,300+ scientists supported globally

We are the Cancer Research Institute

Since 1953, we've led the field with support for immunotherapy research and clinical trials. Together with our donor, patient, and scientist communities, we continue to fund revolutionary breakthroughs to cure all types of cancer.

Learn more about our strategy and impact

Why Cancer Immunotherapy?

By harnessing the innate powers of the body's immune system, immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cures for all types of cancer. Immunotherapy is already saving lives, and while responses vary from patient to patient, with further research, we can bring more effective treatments to more cancer patients.

See how immunotherapy works

Funding the Best Scientists

See Where Your Money Goes

All Together for Team CRI

Fundraise for immunotherapy

I'm the Answer to Cancer

Share Stories and Connect

Partners in Progress

Become a corporate sponsor

News & Events

March 27, 2020
Vaccine-Chemo Combo Shows Promise
Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists l...
Read Article
March 25, 2020
COVID-19 and the Immune System
Lessons learned from cancer immunotherapy research may help to curb the COVID-19 p...
Read Article
April 18, 2020
(CANCELED) Patient Summit in Buffalo
Free event for patients, caregivers, and advocates to learn about new breakthrough...
Read More
November 04, 2019
Trends in Global PD-1/PD-L1 Immunotherapy
Updated report on trends in global PD-1/PD-L1 immunotherapy clinical development f...
Read Release

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

(800) 992-2623(212) 832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

Combined with chemotherapy, an HPV-targeting vaccine developed by CRI scientists led to encouraging responses in women with advanced cervical cancer.

Lessons learned from cancer immunotherapy research may help to curb the COVID-19 pandemic.
Top